
The Canadian health agency, Health Canada, has approved Novo Nordisk's obesity drug Wegovy.
This was revealed in a press release on Thursday, which also stated that the company expects to launch the drug in the country in fall 2022.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app